Evidence map›Paper›PMID 39309664›Full record

ArticleJACC. Advances2024

Von Willebrand Factor Activity Association With Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair.

Sandra Hadjadj, Philippe Pibarot, Caroline Gravel, Marie-Annick Clavel, Ons Marsit, Dounia Rouabhia, Benoît M Labbé, Kim O'Connor, Mathieu Bernier, Erwan Salaun and 5 more

Abstract read
In one paragraph

Article in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sandra HadjadjQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Philippe PibarotQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Caroline GravelQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Marie-Annick ClavelQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Ons MarsitQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Dounia RouabhiaQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Benoît M LabbéQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Kim O'ConnorQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Mathieu BernierQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Erwan SalaunQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Julio FarjatQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Jorge Nuche BerenguerQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Josep Rodés-CabauQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Jean-Michel ParadisQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.
Jonathan BeaudoinQuebec Heart and Lung Institute - Laval University, Quebec, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Residual mitral regurgitation (MR) is associated with worse outcomes after transcatheter edge-to-edge mitral valve repair (TEER). Shear stress induced by MR leads to altered von Willebrand factor activity (vWF:Act) and increased closure time with adenosine diphosphate (CT-ADP). Objectives: The purpose of this study was to investigate the use of CT-ADP to monitor MR during TEER and the association between the vWF, residual MR, and clinical events post-TEER. Methods: Sixty-five patients undergoing TEER were enrolled. CT-ADP was measured at baseline, after each clip deployment, 1 hour and 24 hours post-TEER. CT-ADP values were related to vWF:Act/vWF antigen (vWF:Ag) ratio at the same time points, and MR severity was assessed by echocardiography at 1 month. Combined events of all-cause mortality and heart failure hospitalizations were evaluated at 1 year. Results: At 1 month, 32 (49%) patients had residual MR > mild (of those, 14% had MR > moderate). There was no significant change in CT-ADP values during the procedure. However, CT-ADP significantly decreased 1-hour post-TEER ( Conclusions: CT-ADP evolution in time was not quick enough to provide real-time monitoring of MR severity during TEER. However, vWF:Act/vWF:Ag ratio at baseline and its variations following the procedure were associated with clinical outcomes. Those findings will need external validation.

Indexed as

CT-ADPMitraCliptranscatheter mitral valve repairvon Willebrand diseasesvon Willebrand factor

Identifiers

PMID39309664
PMCPMC11414672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.